ethyl 2,5-dihydroxycinnamate has been researched along with lavendustin a in 1 studies
| Studies (ethyl 2,5-dihydroxycinnamate) | Trials (ethyl 2,5-dihydroxycinnamate) | Recent Studies (post-2010) (ethyl 2,5-dihydroxycinnamate) | Studies (lavendustin a) | Trials (lavendustin a) | Recent Studies (post-2010) (lavendustin a) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 174 | 0 | 5 |
| Protein | Taxonomy | ethyl 2,5-dihydroxycinnamate (IC50) | lavendustin a (IC50) |
|---|---|---|---|
| Estrogen receptor beta | Mus musculus (house mouse) | 8 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 4.1 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 8 | |
| Estrogen receptor | Mus musculus (house mouse) | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Zarruk, AA; van den Berg, HW | 1 |
1 other study(ies) available for ethyl 2,5-dihydroxycinnamate and lavendustin a
| Article | Year |
|---|---|
The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cinnamates; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation; Genistein; Humans; Phenols; Protein-Tyrosine Kinases; Tamoxifen; Tumor Cells, Cultured | 1999 |